Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
Darya Kizub, Jieling Miao, Mark M. Schubert, Alexander Paterson, Mark Clemons, Elizabeth Claire Dees, James N. Ingle, Carla I. Falkson, William E. Barlow, Gabriel N. Hortobágyi, Julie R. Gralow
Topics & Concepts
MedicineBreast cancerBisphosphonateStage (stratigraphy)OncologyPain medicineOsteonecrosis of the jawRandomized controlled trialBisphosphonate-associated osteonecrosis of the jawNursing researchInternal medicineCancerProspective cohort studyAdjuvantOsteoporosisAnesthesiologyPathologyBiologyPaleontologyBone health and treatmentsOral health in cancer treatmentHead and Neck Cancer Studies